Clinical Trial Update: Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea [Phase 2]

View source ↗

Summary

Phase 2 trial results for CB-01-11 200mg tablets in infectious diarrhoea have been completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infectious Diarrhoea

Drugs mentioned

• CB-01-11

Snippet

Sponsor: Cosmo Technologies Ltd | Conditions: Infectious Diarrhoea | Phase 2 | Status: COMPLETED | Results posted: 2018-10-09